Cancer Monoclonal Antibodies Industry Size to Reach US$ 424,628 Million by 2031
The global Cancer Monoclonal Antibodies Market is witnessing rapid expansion due to the increasing prevalence of cancer, rising investments in targeted therapies, and continuous advancements in biotechnology. Monoclonal antibodies have become one of the most effective treatment approaches in oncology …